Brief: Synthaverse Signs Agreements With Blau Farmacéutica Worth 168.9 Mln Zlotys
Dec 18 (Reuters) - Synthaverse SA SVEP.WA :
* SIGNS TWO AGREEMENTS WITH BLAU FARMACÉUTICA
* BLAU GRANTED LICENSE FOR ONKO IN ARGENTINA, COLOMBIA,
PERU,
ECUADOR, CHILE, PARAGUAY
* BLAU ALSO GRANTED LICENSE FOR ONKO IN BRAZIL
* MINIMUM VALUE OF ORDERS FOR AGREEMENT 1 SET AT 23.63
MILLION
EUROS
* MINIMUM VALUE OF ORDERS FOR AGREEMENT 2 SET AT 16.02
MILLION
EUROS
* TOTAL VALUE OF BOTH AGREEMENTS IS 168.89 MILLION ZLOTY
Source text: ID:nEM7FSNXka
Further company coverage: SVEP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility